Periostin has been recognised as a biomarker for chronic rhinosinusitis comorbid in patients with severe asthma; thus, we describe the following part regarding the utility of serum periostin for chronic rhinosinusitis (CRS). This evidence concerns the gene POSTN and congenital rubella syndrome.